## Abstract ## Objective To examine the rates of and risk factors for neutropenia together with the dynamics of neutrophil and other white cell subset counts in a cohort of patients treated with a tumor necrosis factor (TNF) inhibitor for inflammatory arthritis. ## Methods We performed a retrosp
Anti–tumor necrosis factor therapy and cancer risk in patients with autoimmune disorders
✍ Scribed by Karen B. Onel; Kenan Onel
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2010
- Tongue
- English
- Weight
- 66 KB
- Volume
- 62
- Category
- Article
- ISSN
- 2151-464X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To assess the possible effects of both inflammation and the anti–tumor necrosis factor agents (anti‐TNF) on DNA damage with a specific assay, and their effects on the repair capacity of DNA. ## Methods From a group of 20 children with juvenile idiopathic arthritis (JIA),
## Abstract ## Objective Granulomatous inflammation is a typical feature of Takayasu arteritis (TA), and tumor necrosis factor (TNF) is important in the formation of granulomas. In this study, we assessed therapy with anti‐TNF agents in patients with TA that was not controlled by glucocorticoid th
## Abstract ## Objective To assess the association between the initiation of anti–tumor necrosis factor α (anti‐TNFα) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific disease‐modif